Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: tom r. phillips who wrote (335)	9/20/2000 9:49:27 AM
From: tom r. phillips	Respond to of 668

quote re OP-1 from yesterday's webcast, posted on Yahoo CRIS board: (CEO Doros Platika, MD) "The status is that it's been filed for approval in the US, Europe and Australia. There will be mid-teens royalties from Stryker to Curis. Stryker has stated that they anticipate that OP-1 will be sold in one of these three markets by the end of this year, and in discussions with analysts have stated that the European authorities have site-visited its manufacturing plant in the Boston area." looking good. tom